Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» September 2011
September 2011
Pfizer a Step Closer to Icagen
Pfizer a Step Closer to Icagen
Yahoo/Zacks.com
Pfizer
M&A
Icagen
Abbott's Management Is Creating Value
Abbott's Management Is Creating Value
Motley Fool
Abbott Laboratories
Dendreon Shareholders May Yet Have The Last Laugh
Dendreon Shareholders May Yet Have The Last Laugh
Seeking Alpha
Dendreon
Provenge
prostate cancer
shareholders
Seattle Genetics
Top High-Dividend Healthcare Stocks
Top High-Dividend Healthcare Stocks
Seeking Alpha
dividends
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
FDA phases out OTC asthma inhalers due to environmental impact
FDA phases out OTC asthma inhalers due to environmental impact
Seattle Post Intelligencer, WA
asthma
OTC
inhaler
FDA
Twitter as biopharma radar
Twitter as biopharma radar
Fierce Pharma Manufacturing
social media
twitter
RXi Licenses Novel, Targeted Cancer Vaccine for Gynecological Cancers
RXi Licenses Novel, Targeted Cancer Vaccine for Gynecological Cancers
Yahoo/Zacks.com
vaccines
RXi Pharmaceuticals
ovarian cancer
gynecological cancers
Novartis Unveils Upbeat ACZ885 Data
Novartis Unveils Upbeat ACZ885 Data
Yahoo/Zacks.com
ACZ885
Novartis
systemic juvenile idiopathic arthritis
Why Bristol-Myers Squibb's Earnings Are Outstanding
Why Bristol-Myers Squibb's Earnings Are Outstanding
Motley Fool
earnings
Bristol-Myers Squibb
Sanofi tackles $3B acne market with UC San Diego pact
Sanofi tackles $3B acne market with UC San Diego pact
Fierce Biotech
vaccines
acne
Sanofi Pasteur
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »